Twitxy
Saved
@Thalcin's profile picture
View on X

Thierry Alcindor, MD, MSc

@Thalcin

Oncologue médical/Hématologue, sarcomes et tumeurs digestives|Medical oncologist/Hematologist, sarcomas and GI |@danafarbernews and @harvardmed
Boston, MA Joined December 2017
653 Following 1K Followers 876 Posts

Latest posts 5

Thierry Alcindor, MD, MSc @Thalcin
For those of you attending #CTOS2026, an invitation to this educational event on #desmoid tumors, organized by @PeerView for CME. Happy to share the podium with @GinaDAmatoMD1 and Bernd Kasper.
PeerView Verified account @PeerView Oct 21
Get current on how contemporary imaging, diagnostic workups, and the latest clinical data and guidelines on gamma secretase inhibitors are reshaping decisions around desmoid tumors with Drs. Alcindor (@Thalcin), D'Amato (@GinaDAmatoMD1), and Kasper in #DesmoidTumors on 11/18 at 7:30 PM KST: bit.ly/Seoul26-DT-T

Thank you to our partner @DTRFoundation and educational grant supporters @Immunome and Springworks Therapeutics.

#CTOS2026 #Oncology #MedEd
View quoted post on X
0 replies 5 reposts 12 likes 388 views View on X
Thierry Alcindor, MD, MSc @Thalcin
So much is happening with desmoid tumors! Looking forward to our symposium in Seoul, South Korea, along with co-presenters.#CTOS2026
PeerView Verified account @PeerView Oct 7
Join us Wednesday, 11/18, at 7:30 PM KST for our #DesmoidTumor symposium, featuring Drs. Alcindor (@Thalcin), D'Amato (@GinaDAmatoMD1) and Kasper, during #CTOS2026 bit.ly/Seoul26-DT-T #Oncology
View quoted post on X
Thierry Alcindor, MD, MSc @Thalcin
Perioperative Avelumab and Chemotherapy for Gastroesophageal Adenocarcinoma: Long‐Term Survival Outcomes - Alcindor - International Journal of Cancer - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/ij…
60% of patients were alive at 5 years, supporting the chemoimmunotherapy approach.
onlinelibrary.wiley.com Perioperative Avelumab and Chemotherapy for Gastroesophageal Adenocarcinoma: Long‐Term Survival... Long-term survival data for patients with locally advanced gastro-esophageal adenocarcinoma (GEA) treated with neoadjuvant chemoimmunotherapy are lacking. We describe the long-term disease-free...